WebAug 4, 2024 · Here, we characterize the structural basis and mechanistic outcomes of lenalidomide-induced sequestration of eIF3i from the eIF3 complex. Identification of the binding interface on eIF3i by a covalent lenalidomide probe and chemical proteomics rationalizes the sequestration event. We further connect eIF3i and CRBN to known … WebThe Woo lab draws from the fields of chemical biology, organic synthesis, and mass spectrometry to understand small molecule activity in the proteome. We seek to develop …
Christina Woo Chemical Biology PhD - Harvard University
WebChristina Woo. Associate Professor of Chemistry and Chemical Biology Description; Department of Chemistry and Chemical Biology Mallinckrodt 314 12 Oxford Street Cambridge, MA 02138 Tel: 617-496-9921 Email: … WebChristina Woo. Page 1 of 1. New approach to slowing aggressive leukemia Compounds that degrade proteins, block cell growth developed by Harvard researchers hold promise as treatment for more types of cancer. Health Date ... spine itching
Chemical biology studies of the thalidomide binding domain of …
WebFeb 9, 2024 · Bio: Christina M. Woo is an Associate Professor in the Department of Chemistry and Chemical Biology at Harvard University, and an affiliate member of the … WebChristina M. Woo, Ph.D. Associate Professor Department of Chemistry and Chemical Biology Harvard University About Christina CV . Current team (click image for bio) ... Hung-Yi Wu (Harvard Medical School) Visiting … WebMar 31, 2024 · New approach to slowing aggressive leukemia. Research assistants David Miyamoto (from left) and Nicole Curnutt work with Associate Professor Christina Woo to create protein-degradation strategies that will be useful in developing cancer treatments. Kris Snibbe/Harvard Staff Photographer. spine issues in french bulldogs